What one share of ANI Pharmaceuticals holds
ANI Pharmaceuticals is a diversified bio-pharmaceutical company. The Company's mission is “Serving Patients, Improving Lives” by developing, manufacturing, and commercializing therapeutics through its Rare Disease, Generics, and Brands businesses.
ANI Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $44.42 |
|---|---|
| Profit | $4.48 |
| Capex (buildings and equipment) | $0.75 |
| Free cash flow | $7.85 |
| Dividends | $0.02 |
| Cash and investments | $17.02 |
| Debt | $14.25 |
| Book value | $28.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$8.40 | $0.03 | −$3.29 | — | $2.80 |
| 2010 | — | −$4.21 | $0.01 | −$3.66 | — | $1.74 |
| 2011 | — | −$3.15 | $0.04 | −$2.96 | — | −$1.70 |
| 2014 | $5.06 | $2.59 | $0.10 | $1.89 | — | $12.78 |
| 2015 | $6.60 | $1.32 | $0.19 | $1.30 | — | $14.08 |
| 2016 | $11.11 | $0.34 | $0.39 | $1.98 | — | $14.82 |
| 2017 | $15.31 | −$0.09 | $0.90 | $2.52 | — | $15.13 |
| 2018 | $17.12 | $1.30 | $0.49 | $5.21 | — | $16.89 |
| 2019 | $17.16 | $0.50 | $0.55 | $3.24 | — | $17.97 |
| 2020 | $17.43 | −$1.88 | $0.51 | $0.76 | — | $16.36 |
| 2021 | $17.16 | −$3.40 | $0.20 | $0.06 | — | $26.51 |
| 2022 | $19.46 | −$3.05 | $0.55 | −$2.46 | — | $19.29 |
| 2023 | $26.76 | $0.85 | $0.49 | $6.05 | — | $24.04 |
| 2024 | $31.80 | −$1.04 | $0.84 | $2.47 | — | $19.12 |
| 2025 | $41.61 | $3.32 | $0.65 | $8.07 | — | $24.04 |
Common questions about ANI Pharmaceuticals
How much does one share of ANI Pharmaceuticals earn?
Over the last 12 months, each share of ANI Pharmaceuticals earned $4.48 of profit on $44.42 of sales, keeping about 10¢ of every $1 (profit margin).
Does ANI Pharmaceuticals pay a dividend?
Yes. ANI Pharmaceuticals paid $0.02 per share in dividends over the last 12 months. That’s about 0¢ of each $1 of profit (payout ratio).
What is ANI Pharmaceuticals’s book value per share?
ANI Pharmaceuticals’s book value is $28.23 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of ANI Pharmaceuticals have?
Each share of ANI Pharmaceuticals has $17.02 of cash and investments and $14.25 of debt, as of June 30, 2026.
What is ANI Pharmaceuticals’s free cash flow per share?
$7.85 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has ANI Pharmaceuticals bought back shares?
ANI Pharmaceuticals’s share count rose about 275% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.